RZLT Rezolute, Inc.

NASDAQ
$4.07

Rezolute, Inc. (RZLT) is expected to report earnings on December 24, 2026, after the market close. The consensus earnings estimate is a loss of $0.18 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.0% since its last earnings release on September 24, 2026.

Rezolute Missed Consensus Estimates
Thursday, September 24, 2026 · 4:05 PM ET
Earnings Date
1st Quarter, Sep 2026
Dec 24
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.18)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.07

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Rezolute, Inc.

Rezolute strives to disrupt current treatment paradigms by developing transformative therapies for devastating rare and chronic metabolic diseases.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.